Stop spending months on site feasibility. Upload your protocol parameters and our AI matches you to verified CROs, academic centers, and dedicated early-phase units — in minutes, not quarters.
The Problem
of clinical trials fail to meet original enrollment timelines
Tufts Center for the Study of Drug Development, 2023
months average site startup time from selection to first patient in
IQVIA Site Intelligence Report, 2024
average cost per month of trial delay for a Phase III oncology study
Pharma Intelligence, 2023
Our algorithm scores every site in our network against your protocol parameters — therapeutic focus, phase capability, geographic scope, budget, and timeline.
Every site is pre-qualified with verified enrollment rates, historical study counts, and performance metrics. No more relying on sales decks.
From single academic centers to global CRO networks — find the right mix of scientific credibility and operational speed.
Get realistic startup timelines based on site workload, regulatory pathway, and seasonal enrollment patterns.
Per-patient cost estimates and total site budget projections before you send a single feasibility questionnaire.
Automated regulatory considerations for IND/CTA submissions, biomarker protocols, and multi-regional trial design.
CTMatch Protocol Assessment
~5 minutes. Your protocol parameters. Our verified site network. Matched in minutes.
Step 1 of 3
Confidentiality: Use a protocol code name only. Do not enter drug names, molecule IDs, or proprietary protocol numbers.
Legal Disclaimer: CTMatch is provided for strategic decision-support purposes only and does not constitute clinical, regulatory, or operational advice. All site selection decisions should be independently verified through formal feasibility assessments and site qualification visits. © 2026 Bridge BioHealth Consulting LLC.
We use cookies to improve your experience.
We use essential and analytics cookies to operate our platform and understand how visitors use it. See our Privacy Policy for details.